These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9052965)

  • 1. [The renal dopaminergic system and arterial hypertension].
    Pestana M; Guerra L
    Rev Port Cardiol; 1996 Dec; 15(12):893-902. PubMed ID: 9052965
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dopamine in the kidney: a further natriuretic hormone?].
    Unger T; Ganten D; Lang RE
    Fortschr Med; 1985 Apr; 103(14):357-60. PubMed ID: 3997009
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of dopamine in the pathogenesis of hypertension.
    Jose PA; Eisner GM; Felder RA
    Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S10-3. PubMed ID: 10386248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic receptors: a new antihypertensive mechanism.
    Velasco M; Contreras F; Cabezas GA; Bolívar A; Fouillioux C; Hernández R
    J Hypertens Suppl; 2002 Jun; 20(3):S55-8. PubMed ID: 12184056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Involvement of dopamine receptor in the pathogenesis of hypertension and hypertensive target-organ damage].
    Sanada H; Yatabe J; Sasaki M; Watanabe T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():160-3. PubMed ID: 15171362
    [No Abstract]   [Full Text] [Related]  

  • 6. [The renal dopaminergic system in chronic diseases of the renal parenchyma].
    Pestana M
    Rev Port Cardiol; 1998; 17(7-8):635-43. PubMed ID: 9741219
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine, hypertension and obesity.
    Contreras F; Fouillioux C; Bolívar A; Simonovis N; Hernández-Hernández R; Armas-Hernandez MJ; Velasco M
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S13-7. PubMed ID: 11986886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endogenous dopamine on renal sodium excretion.
    Felder RA; Robillard J; Eisner GM; Jose PA
    Semin Nephrol; 1989 Mar; 9(1):91-3. PubMed ID: 2662307
    [No Abstract]   [Full Text] [Related]  

  • 9. The dopaminergic system in hypertension.
    Zeng C; Zhang M; Asico LD; Eisner GM; Jose PA
    Clin Sci (Lond); 2007 Jun; 112(12):583-97. PubMed ID: 17492945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine: vascular and renal effects and alterations in hypertension.
    Elghozi JL; Earnhardt JT; Meyer P
    Adv Nephrol Necker Hosp; 1984; 13():135-50. PubMed ID: 6433664
    [No Abstract]   [Full Text] [Related]  

  • 11. [Perspectives in the treatment of arterial hypertension: interventions at the dopaminergic system level].
    Soares-da-Silva P
    Rev Port Cardiol; 1988; 7(2):191-210. PubMed ID: 2908515
    [No Abstract]   [Full Text] [Related]  

  • 12. [Arterial hypertension caused by aortic coarctation in dogs. Renal hemodynamics and pressure natriuresis].
    Praxedes JN; Malheiro PS; Barros RT; Silva HB; Marcondes M
    Arq Bras Cardiol; 1986 May; 46(5):301-6. PubMed ID: 3566562
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine receptors in hypertension.
    Bek MJ; Eisner GM; Felder RA; Jose PA
    Mt Sinai J Med; 2001 Nov; 68(6):362-9. PubMed ID: 11687863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renalase, hypertension, and kidney - the discussion continues.
    Malyszko J; Malyszko JS; Rysz J; Mysliwiec M; Tesar V; Levin-Iaina N; Banach M
    Angiology; 2013 Apr; 64(3):181-7. PubMed ID: 22969162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peripheral dopaminergic system: morphological analysis, functional and clinical applications.
    Amenta F; Ricci A; Tayebati SK; Zaccheo D
    Ital J Anat Embryol; 2002; 107(3):145-67. PubMed ID: 12437142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressed dopaminergic activity and water-sodium handling in the kidneys at the prehypertensive stage of essential hypertension.
    Iimura O; Shimamoto K
    J Auton Pharmacol; 1990; 10 Suppl 1():s73-7. PubMed ID: 2098378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine and the kidney.
    Smit AJ
    Neth J Med; 1989 Feb; 34(1-2):47-58. PubMed ID: 2644557
    [No Abstract]   [Full Text] [Related]  

  • 18. Symposium on the etiology of hypertension--summarizing studies in 20th century. 4. Pathogenesis of hypertension--kidney as a pathogenetic organ of hypertension.
    Hayashi K
    Intern Med; 2001 Feb; 40(2):153-6. PubMed ID: 11300152
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dopaminergic systems and their targets].
    Tassin JP
    Encephale; 1989; 15 Spec No():63-72. PubMed ID: 2663448
    [No Abstract]   [Full Text] [Related]  

  • 20. The therapeutic potential of dopamine modulators on the cardiovascular and renal systems.
    Doggrell SA
    Expert Opin Investig Drugs; 2002 May; 11(5):631-44. PubMed ID: 11996645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.